Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Ken Griffin Warns Trump-Era Political вмешening Is Distorting Corporate Decision-Making

by Team Lumida
18 hours ago
Ken Griffin Warns Trump-Era Political вмешening Is Distorting Corporate Decision-Making

Key takeaways Powered by lumidawealth.com Ken Griffin said CEOs increasingly view government interference in corporate affairs as “distasteful” and harmful to market integrity. He accused the administration of favoritism...

Read more

Google Moves to “Own the Power” for AI, Betting $4.75B on Energy Supply Control

by Team Lumida
2 days ago
China Stimulus: Enough to Sway Markets?

Key takeaways Powered by lumidawealth.com Google plans to acquire Intersect for $4.75B, aiming to lock in electricity supply for its expanding data-center footprint. The deal would make Alphabet the...

Read more

SpaceX Buys xAI, Creating a $1.25T Musk “Vertical Stack” Across Rockets, Satellites, and AI

by Team Lumida
2 days ago
Musk and Trump’s Friendship: What It Means for the EV Market

Key takeaways Powered by lumidawealth.com A major consolidation: SpaceX acquired xAI, bringing Musk’s rocket/satellite platform and AI model efforts under one roof. Valuation signal: The combined company is valued...

Read more

Oracle Corp Plans $45–$50B Capital Raise to Fund AI Cloud Buildout as Cash Flow Turns Negative

by Team Lumida
3 days ago
Oracle’s Q4 earnings missed expectations but stock jumped ~11% after new cloud deals

Key takeaways Powered by lumidawealth.com Oracle Corp plans to raise $45–$50B in 2026 (mix of equity and debt) to expand cloud infrastructure for AI-driven demand. The company says it...

Read more

China’s Metals Trading Web Unravels After Key Dealer Flees, Exposing Hidden Risk

by Team Lumida
3 days ago
gold and silver round coins

Key takeaways Powered by lumidawealth.com Chinese metals traders have suffered at least ¥1 billion ($144 million) in losses after a major counterparty abruptly fled the country. The fallout centers...

Read more

Apple Delivers iPhone Blowout, but AI-Era Component Inflation Becomes the New Investor Risk

by Team Lumida
6 days ago
Why Apple’s AI Approach May Save Its Reputation

Key takeaways Powered by lumidawealth.com iPhone revenue rose 23% to $85.3B, pushing Apple to record quarterly sales near $144B and beating expectations. China demand strengthened, helping stabilize a region...

Read more

Corporate America Keeps Cutting: Post-Pandemic Overhiring Meets Higher Rates and AI Spending

by Team Lumida
6 days ago
Are Your Job Gains at Risk? What the Tight Market Means Now

Key takeaways Powered by lumidawealth.com Large employers are still reducing headcount after pandemic-era hiring surged, with cuts concentrated in tech and logistics. Amazon is planning another 16,000 corporate layoffs;...

Read more

Tesla Doubles Down on AI and Robotics With $20B Capex, Cuts Model S/X, Invests $2B in xAI

by Team Lumida
7 days ago
blue coupe parked beside white wall

Key takeaways Powered by lumidawealth.com Tesla plans ~$20B in 2026 capex—about double what Wall Street expected—to expand factories, scale robotaxi, and build AI infrastructure. The company will discontinue Model...

Read more

Dollar Slide Rewrites the Playbook for Travel, Trade—and “Buy America” Capital Flows

by Team Lumida
7 days ago
Dollar Slide Rewrites the Playbook for Travel, Trade—and “Buy America” Capital Flows

Key takeaways Powered by lumidawealth.com The dollar has fallen to its lowest level since 2022, reviving concerns that US market dominance may be fading The move is reshaping real-world...

Read more

Goldman Flags Base-Metals Rally Risk as China Demand Softens and Buyers Pull Back

by Team Lumida
1 week ago
Goldman’s Big Bet on Wealth Lending: Doubling Down on the Ultra-Rich

Key takeaways Powered by lumidawealth.com Goldman says the base-metals rally is running into real-economy demand resistance, especially in China A copper-market survey showed fabricators’ order books down 10%–30% as...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Global Markets Mixed as Investors Await Nvidia Earnings and Monitor Rising Bond Yields

Global Markets Mixed as Investors Await Nvidia Earnings and Monitor Rising Bond Yields

May 28, 2025
Trump Energy Department Dismantles Key Clean-Energy Offices, Redirecting Policy Toward Fossil Fuels

Trump Energy Department Dismantles Key Clean-Energy Offices, Redirecting Policy Toward Fossil Fuels

November 21, 2025
Can U.S. Manufacturing Compete? Billions Later, China Still Leads

Can U.S. Manufacturing Compete? Billions Later, China Still Leads

August 3, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018